Article Information
History
- September 8, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Anna L Silverman, MD1,2,*,
- Madhumita Sushil, PhD3,*,
- Balu Bhasuran, PhD3,*,
- Dana Ludwig, MD3,
- James Buchanan, PharmD3,
- Rebecca Racz, PharmD4,
- Mahalakshmi Parakala5,
- Samer El-Kamary, MD, MPH4,+,
- Ohenewaa Ahima, MD4,
- Artur Belov, PhD4,
- Lauren Choi, PharmD4,
- Monisha Billings, DDS, MPH, PhD4,
- Yan Li, B.Pharm, Ph.D.4,
- Nadia Habal, MD4,
- Qi Liu, PhD4,
- Jawahar Tiwari, PhD4,
- Atul J Butte, PhD3,6 and
- Vivek A Rudrapatna, MD, PhD3,7,#
- 1Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA
- 2Department of Medicine, University of California, San Diego, La Jolla, CA, USA
- 3Bakar Computational Health Sciences Institute, San Francisco, CA, USA
- 4United States Food and Drug Administration, Silver Spring, MD, USA
- 5Department of Public Health, University of California Berkeley, Berkeley, USA
- 6Center for Data-Driven Insights and Innovation, University of California Health, Oakland, CA, USA
- 7Division of Gastroenterology and Hepatology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA
- ↵#Corresponding Author:
Vivek A. Rudrapatna, MD, PhD, Assistant Professor of Medicine, University of California, San Francisco Bakar Institute, Box 2993, 490 Illinois Street, Floor 2, San Francisco, CA 94143, Email: vivek.rudrapatna{at}ucsf.edu
↵* These authors contributed equally to this work and share first authorship.
Posted September 08, 2023.
Algorithmic identification of treatment-emergent adverse events from clinical notes using large language models: a pilot study in inflammatory bowel disease
